Literature DB >> 17038456

Behcet's disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatment.

K Baki, P M Villiger, D Jenni, T Meyer, J H Beer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17038456      PMCID： PMC1798365          DOI： 10.1136/ard.2005.045195

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Behçet's syndrome: where do we stand?

Authors:  Hasan Yazici
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

2.  Pulmonary artery aneurysms in Behçet syndrome.

Authors:  Vedat Hamuryudan; Tarik Er; Emire Seyahi; Canan Akman; Hasan Tüzün; Izzet Fresko; Sebahattin Yurdakul; Füruzan Numan; Hasan Yazici
Journal:  Am J Med       Date:  2004-12-01       Impact factor: 4.965

3.  Arterial lesions in Behçet's disease.

Authors:  D Saba; H Saricaoğlu; A S Bayram; C Erdoğan; K Dilek; C Gebitekin; H Ozkan; Z G Ozer
Journal:  Vasa       Date:  2003-05       Impact factor: 1.961

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

5.  Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders.

Authors:  Daniel Aeberli; Stefan Oertle; Heribert Mauron; Stephan Reichenbach; Beat Jordi; Peter M Villiger
Journal:  Swiss Med Wkly       Date:  2002-07-27       Impact factor: 2.193

Review 6.  Behçet's disease: a new target for anti-tumour necrosis factor treatment.

Authors:  P P Sfikakis
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103
  6 in total
  7 in total

Review 1.  Cardiovascular involvement in Behçet's disease.

Authors:  Yusuf Sezen; Hakan Buyukhatipoglu; Hakan Buyukatipoglu; Zekeriya Kucukdurmaz; Ramazan Geyik
Journal:  Clin Rheumatol       Date:  2009-10-16       Impact factor: 2.980

2.  Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Behçet's disease.

Authors:  Suhail Aamar; Hagit Peleg; David Leibowitz; Tova Chajek-Shaul; Nurith Hiller; Samuel N Heyman
Journal:  Rheumatol Int       Date:  2013-02-15       Impact factor: 2.631

Review 3.  Intracardiac thrombus in Behçet's disease: four new cases and a comprehensive literature review.

Authors:  Tolga Aksu; Omac Tufekcioglu
Journal:  Rheumatol Int       Date:  2014-11-09       Impact factor: 2.631

4.  Multiple Right and Left Pulmonary Arteries and Subdivisions of Inferior Mesenteric Artery Aneurysms in Behcet's Disease Case: A Rare Clinical Presentation.

Authors:  Reza Faridhosseini; Farah Jabbari; Afshin Shirkani; Mohammad Reza Zandkarimi; Hadis Yousefzaedh; Maryam Sahebari; Reza Basiri
Journal:  Oman Med J       Date:  2014-05

5.  Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report.

Authors:  Sung-Won Lee; Sang-Yeob Lee; Ki-Nam Kim; Jin-Kyu Jung; Won-Tae Chung
Journal:  Clin Rheumatol       Date:  2009-10-09       Impact factor: 2.980

6.  Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment.

Authors:  M B Owlia; G Mehrpoor
Journal:  ISRN Pharmacol       Date:  2012-03-08

Review 7.  Adalimumab in the management of Behçet's disease.

Authors:  Atsuhisa Ueda; Mitsuhiro Takeno; Yoshiaki Ishigatsubo
Journal:  Ther Clin Risk Manag       Date:  2015-04-13       Impact factor: 2.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.